文献速递临床试验与 GCP

主动脉手术中急性等容血液稀释与自体富血小板血浆血液保护效果的比较:随机对照临床试验研究方案

Comparing acute normovolumic hemodilution with autologous platelet-rich plasma for blood preservation during aortic surgery : study protocol for a randomized controlled clinical trial.
PubMed 文献 · Trials · 2023-11-18

本研究为前瞻性、单中心、双盲对照临床试验,计划纳入160例主动脉手术患者,按1:1随机分为自体富血小板血浆(aPRP)组与急性等容血液稀释(ANH)对照组,主要比较术后24、48、72小时引流量,并观察异体血制品输入、主动脉阻断时间、体外循环时间等次要结局,旨在评估aPRP是否较ANH降低术后出血风险。

要点

  • 拟纳入160例主动脉手术患者,1:1随机接受aPRP或ANH。
  • 主要终点为术后24、48、72小时引流量。
  • 次要终点包括异体血输入、主动脉阻断及体外循环时间等。

核心结论

  • 本研究将验证与ANH相比,aPRP是否能降低主动脉手术后出血风险。
  • 结果有望在更有效血液保护和缩短住院时间方面具有实际临床应用价值。

研究设计与样本

  • 前瞻性、单中心、双盲对照临床试验,纳入160例患者,按1:1随机分为aPRP组(试验组)或自体全血ANH组(对照组)。

主要发现

  • 主要目标为比较两组术后24、48、72小时引流量。
  • 次要结局包括两组异体血及血制品输入量、主动脉阻断时间、体外循环时间、深低温停循环时间、气管拔管时间、住院时间、二次手术止血需求、主动脉内球囊反搏或体外膜肺氧合的应用。
  • 还将比较两组在血液保存前(T1)、血液保存后(T2)、输血前(T3)及血液回输后(T4)的心率、收缩压、舒张压、中心静脉压及血栓弹力图。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both acute normovolumic hemodilution (ANH) and autologous platelet-rich plasma (aPRP) have been demonstrated blood-protective effects in cardiac aortic surgery; however, the efficacies of the two methods have not been compared. This study aims to compare the effects of aPRP and ANH prior to aortic surgery on postoperative bleed and other outcomes. METHODS AND ANALYSIS: This is a prospective, single-center, double-blind controlled clinical trial including 160 patients randomized 1:1 to receive aPRP (test group) or autologous whole blood (ANH, control group). The primary objective is to compare the drainage volumes in the two groups at 24, 48, and 72 h postoperatively. Secondary outcomes include input of allogeneic blood and blood products and durations of aortic block, extracorporeal circulation, deep hypothermic arrest of circulation, tracheal extubation, hospital stay, requirement for secondary surgical hemostasis, and application of intra-aortic balloon pump or extracorporeal membrane oxygenation in the two groups. In addition, heart rate, systolic blood pressure, diastolic blood pressure, central venous pressure, and thromboelastography recorded before blood reservation (T1), after blood reservation (T2), before blood transfusion (T3), and after the blood is returned (T4) to the transfusion will be compared between the two groups of patients. DISCUSSION: This study will demonstrate if the use of aPRP could reduce the risk of bleeding after aortic surgery compared with ANH. The results are expected to have practical clinical applications in terms of more effective blood protection and shorter hospital stay. TRIAL REGISTRATION: This study was registered with the Chinese Clinical Trial Registry ( http://www.chictr.org.cn/ ) with the ID ChiCTR 1900023351.Registered on May 23, 2019. TRIAL STATUS: Recruiting start date: July 1, 2019; expected recruiting end date: July 1, 2024 Version number and date: Version 2 of 05-04-2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhu D, Li Y, Tian AY, et al. Comparing acute normovolumic hemodilution with autologous platelet-rich plasma for blood preservation during aortic surgery : study protocol for a randomized controlled clinical trial. Trials. 2023. PMID: 37980486. doi:10.1186/s13063-023-07800-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。